Successful 2018 Share Capital Increase Reserved for Arkema Employees

COLOMBES, France--(BUSINESS WIRE)-- Regulatory News:

Over 8,000 Arkema (Paris: AKE) employees have subscribed for 610,405 shares totaling €50 million as part of the sixth capital increase reserved for them. The amounts invested and the high participation rate highlight the employees’ confidence in the Group’s long-term strategy.

Arkema conducted a share capital increase reserved for employees on 26 April 2018, the sixth such operation since its stock market listing 12 years ago.

8,413 subscriptions were registered in 31 countries, totaling €50 million. The employee participation rate increased compared to the previous operation in 2016, reaching 69% in France and 25% outside France, i.e. 41% on average.

The subscription period took place from 9 to 22 March 2018, with a subscription price of €81.97 per share.

At the close of the operation, 610,405 shares were created, taking employee shareholding to around 6%.

The newly issued Arkema shares will bear rights from 1st January 2017, with entitlement to dividend payment in 2018.

A designer of materials and innovative solutions, Arkema shapes materials and creates new uses that accelerate customer performance. Our balanced business portfolio spans high-performance materials, industrial specialties and coating solutions. Our globally recognized brands are ranked among the leaders in the markets we serve. Reporting annual sales of €8.3 billion in 2017, we employ approximately 20,000 people worldwide and operate in close to 55 countries. We are committed to active engagement with all our stakeholders. Our research centers in North America, France and Asia concentrate on advances in bio-based products, new energies, water management, electronic solutions, lightweight materials and design, home efficiency and insulation. www.arkema.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20180426005789/en/

Arkema
INVESTOR RELATIONS
Sophie Fouillat +33 1 49 00 86 37
[email protected]
or
François Ruas, +33 1 49 00 72 07
[email protected]
or
MEDIA
Gilles Galinier, +33 1 49 00 70 07
[email protected]
ou
Véronique Obrecht, +33 1 49 00 88 41
[email protected]

Source: ARKEMA

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Arkema: Statement About the Number of Shares and Voting Rights in Compliance With the Article L.233-8 II of the French Commercial Code and the Article 223-16 of the Financial Markets Authority (AMF-Au
• The 80/20 Institute Releases a 100-Day Playbook for PE-Backed CEOs Under Value-Creation Pressure
• Understanding Peptide Supplements: PureHealth Research Highlights Morikol® Tripeptides for Joint, Skin, and Hair Wellness